Kolexia
Leguay Thibaut Hématologie
Leguay Thibaut
Hématologie
Hôpital Haut-lévêque
Pessac, France
168 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie aigüe myéloïde Leucémie myéloïde Leucémie-lymphome lymphoblastique à précurseurs T Chromosome Philadelphie Leucémie lymphoïde Leucémie-lymphome lymphoblastique à précurseurs B Maladie résiduelle

Collaborateurs

Voir plus
Huguet Francoise
Huguet Francoise
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Dombret Herve
Dombret Herve
Hôpital Saint-Louis, Paris, France
Pigneux Arnaud
Pigneux Arnaud
Hôpital Haut-lévêque, Pessac, France
Boissel Nicolas
Boissel Nicolas
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
A+A
40 collaboration(s)
Dernière en 2023
P\S\L Group Services
28 collaboration(s)
Dernière en 2023
B3TSI
26 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
18 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Cancer medicine   26 février 2024
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia.
EJHaem   10 janvier 2024
ZUMA-3: A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3)
Essai Clinique (Gilead)   14 novembre 2023
Levofloxacin to Prevent Bacterial Infection in Patients with Acute Myeloid Leukemia Treated By Azacitidine and Venetoclax: A Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1: Time to Reconsider Prognostic Risk? a Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report
65th ASH Annual Meeting Abstracts   02 novembre 2023
Venetoclax and Azacitidine for Molecular Relapse during First Line Intensive Chemotherapy in Patients with NPM1 Mutated or Core Binding Factor (CBF) AML. a Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study
65th ASH Annual Meeting Abstracts   02 novembre 2023